Abiopharma

Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease

Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

UTHR: Notification

Cue Biopharma Announces Proposed Public Offering

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services’s Directors and Officers for Breach of Fiduciary Duties – UHS

Notification from CorMedix Inc.